Accendra Health CEO surrenders shares for taxes

Accendra Health President and CEO Edward A. Pesicka surrendered 17,692 shares of common stock on May 15, 2026 to cover tax withholding obligations tied to vesting of restricted stock.

Rhea-AI Filing Summary

Accendra Health President and CEO Edward A. Pesicka surrendered 17,692 shares of common stock on May 15, 2026 to cover tax withholding obligations tied to vesting of restricted stock. These shares were delivered back to the company rather than sold on the open market. Following this routine tax-withholding disposition, he directly holds 1,072,785 common shares.

Insider Trade Summary

Exercise Price or Tax Liability: 17,692 shares

Exercise Price or Tax Liability 1 txn

Insider Pesicka Edward A

Role President & CEO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	17,692	$3.04	$54K

Holdings After Transaction: Common Stock — 1,072,785 shares (Direct)

Footnotes (1)

1. F1. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

Key Figures

Shares surrendered for taxes: 17,692 shares Transaction price per share: $3.04 per share Shares held after transaction: 1,072,785 shares

3 metrics

Shares surrendered for taxes 17,692 shares Tax-withholding disposition on May 15, 2026

Transaction price per share $3.04 per share Value used for tax-withholding disposition

Shares held after transaction 1,072,785 shares Direct common stock ownership following Form 4 event

Key Terms

restricted stock, tax withholding obligations, Form 4, Payment of exercise price or tax liability by delivering securities

4 terms

restricted stock financial

"in connection with vesting of restricted stock granted to the Reporting Person"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

tax withholding obligations financial

"satisfy tax withholding obligations in connection with vesting of restricted stock"

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Payment of exercise price or tax liability by delivering securities financial

"transaction_code_description": "Payment of exercise price or tax liability by delivering securities""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Accendra Health (ACH) report for Edward Pesicka?

Accendra Health reported that CEO Edward A. Pesicka surrendered 17,692 common shares to the company to satisfy tax withholding obligations from vesting restricted stock, rather than selling shares in the open market.

Was the Accendra Health (ACH) CEO’s Form 4 transaction an open-market sale?

No, the CEO’s Form 4 shows a tax-withholding disposition. 17,692 shares were surrendered back to the issuer to cover taxes on restricted stock vesting, not sold in an open-market transaction.

How many Accendra Health (ACH) shares did the CEO surrender for taxes?

Edward A. Pesicka surrendered 17,692 shares of Accendra Health common stock. The filing describes this as payment of tax withholding obligations related to the vesting of restricted stock previously granted to him.

What is the reported price per share for the Accendra Health (ACH) tax-withholding transaction?

The Form 4 reports a transaction price of $3.04 per share for the 17,692 surrendered shares. This value is used for tax-withholding purposes associated with the vesting restricted stock.

How many Accendra Health (ACH) shares does the CEO hold after this Form 4 transaction?

After surrendering 17,692 shares for tax withholding, Edward A. Pesicka directly holds 1,072,785 Accendra Health common shares, according to the post-transaction ownership figure disclosed in the Form 4.

What does transaction code "F" mean in the Accendra Health (ACH) Form 4?

Transaction code “F” indicates shares were disposed of to pay an exercise price or tax liability. Here, 17,692 shares were surrendered to cover tax withholding on vesting restricted stock awarded to the CEO.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 08:54 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pesicka Edward A

(Last) (First) (Middle)

ACCENDRA HEALTH, INC.

4435 WATERFRONT DRIVE

(Street)

GLEN ALLEN VIRGINIA 23060

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACCENDRA HEALTH INC/VA/ [ ACH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/15/2026		F		17,692(1)	D	$3.04	1,072,785	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

	Edward A. Pesicka, by Rosemarie France POA	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)